IV glucagon use in pediatric MR enterography: Effect on image quality, length of examination, and patient tolerance

American Journal of Roentgenology

Volumn 201, Issue 1, 2013, Pages 185-189

  Dillman, Jonathan R ^a   Smith, Ethan A ^a   Khalatbari, Shokoufeh ^b   Strouse, Peter J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Children; Glucagon; Inflammatory bowel disease; MR enterography; MRI

Indexed keywords

BARIUM; GLUCAGON;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG TOLERABILITY; FEMALE; HUMAN; ILEUM; IMAGE QUALITY; INTESTINE RADIOGRAPHY; LIKERTLIKE SCORE; MAGNETIC RESONANCE ENTEROGRAPHY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SELF REPORT; ULCERATIVE COLITIS; VOMITING; ARTIFACT; DIFFERENTIAL DIAGNOSIS; ENTEROPATHY; INTRAVENOUS ADMINISTRATION; METHODOLOGY; STATISTICAL MODEL; THREE DIMENSIONAL IMAGING; TIME; INTESTINAL DISEASES; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ARTIFACTS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCAGON; HUMANS; IMAGING, THREE-DIMENSIONAL; INTESTINAL DISEASES; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; TIME FACTORS;

EID: 84883422709     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.9787     Document Type: Article

References (17)

1. Brenner DJ. Should computed tomography be the modality of choice for imaging Crohn's disease in children? The radiation risk perspective. Gut 2008; 57:1489-1490
2. Alexopoulou E, Roma E, Loggitsi D, et al. Magnetic resonance imaging of the small bowel in children with idiopathic inflammatory bowel disease: evaluation of disease activity. Pediatr Radiol 2009; 39:791-797
3. Darbari A, Sena L, Argani P, Oliva-Hemker JM, Thompson R, Cuffari C. Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm Bowel Dis 2004; 10:67-72
4. Paolantonio P, Ferrari R, Vecchietti F, Cucchiara S, Laghi A. Current status of MR imaging in the evaluation of IBD in a pediatric population of patients. Eur J Radiol 2009; 69:418-424
5. Silverstein J, Grand D, Kawatu D, Shah SA, Steinkeler J, Leleiko N. Feasibility of using MR enterography (MRE) for the assessment of terminal ileitis and inflammatory activity in children with Crohn's Disease (CD). J Pediatr Gastroenterol Nutr 2012; 55:173-177
6. Gee MS, Nimkin K, Hsu M, et al. Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR 2011; 197:224-231
7. Dillman JR, Ladino-Torres MF, Adler J, et al. Comparison of MR enterography and histopathology in the evaluation of pediatric Crohn disease. Pediatr Radiol 2011; 41:1552-1558
8. Smith EA, Dillman JR, Adler J, DeMatos-Maillard VL, Strouse PJ. MR enterography of extraintestinal manifestations in inflammatory bowel disease in children and adolescents: moving beyond the bowel wall. AJR 2012; 198:W38-W45
9. Fidler JL, Guimaraes L, Einstein DM. MR imaging of the small bowel. RadioGraphics 2009; 29:1811-1825
10. Darge K, Anupindi SA, Jaramillo D. MR imaging of the abdomen and pelvis in infants, children, and adolescents. Radiology 2011; 261:12-29
11. Anupindi SA, Janitz E, Darge K. Bowel imaging in children: a comprehensive look using US and MRI. Semin Roentgenol 2012; 47:118-126
12. Dosdá R, Martí-Bonmatí L, Ronchera-Oms CL, Mollá E, Arana E. Effect of subcutaneous butylscopolamine administration in reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol 2003; 13:294-298
13. Wagner M, Klessen C, Rief M, et al. High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality. Acta Radiol 2008; 49:376-382
14. Brown JJ, Duncan JR, Heiken JP, et al. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991; 181:455-460
15. Froehlich JM, Daenzer M, von Weymarn C, Mehmet-Erturk S, Zollikofer CL, Patak MA. Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging. Eur Radiol 2009; 19:1387-1393
16. Gutzeit A, Binkert C, Koh D, et al. Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration. Eur Radiol 2012; 22:1186-1194
17. Martí-Bonmatí L, Graells M, Ronchera-Oms CL. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging 1996; 21:309-313